Results 211 to 220 of about 18,680 (231)

Deleterious role of IDO1 in cardiac repair

Nature Reviews Cardiology, 2020
openaire   +2 more sources

Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy

European Journal of Medicinal Chemistry, 2022
Yuxi Wang, Changyu Ren, Jifa Zhang
exaly  

IDO1 inhibitors for cancer immunotherapy

Drugs of the Future, 2016
null Alford, B., null Cox, K., null Soliman, H.   +2 more
openaire   +1 more source

Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors

European Journal of Medicinal Chemistry, 2023
Chao Zhang
exaly  

An updated patent review of IDO1 inhibitors for cancer (2018–2022)

Expert Opinion on Therapeutic Patents, 2022
Pengfei Wang
exaly  

Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy

Lung Cancer, 2019
Kazuki Takada, Yoshinao Oda
exaly  

Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities

Trends in Pharmacological Sciences, 2018
Jae Eun Cheong, Lijun Sun
exaly  

Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?

Annual Review of Cancer Biology, 2020
Benoit van den Eynde, Jean-François Baurain   +1 more
exaly  

TDO2 AND IDO1 INHIBITORS

2019
PEI ZHONGHUA, PASTOR RICHARD, GAZZARD LEWIS, PARR BRENDAN, LIU WENDY, MENDONCA ROHAN, WU GUOSHENG, YUEN PO-WAI   +7 more
openaire   +3 more sources

Advances in the discovery and development of selective heme-displacing IDO1 inhibitors

Expert Opinion on Drug Discovery, 2020
Lijun Sun
exaly